MarketCapTrends
LLY

Eli Lilly and Company (LLY)

NYSE · Healthcare

Eli Lilly and Company annual/quarterly long term debt history from 2008 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.

  • Eli Lilly and Company long term debt for the quarter ending December 31, 2025 were 40.87B, a 38.66% increase year-over-year.
  • Eli Lilly and Company long term debt for 2025 were 40.87B, a 38.66% increase from 2024.
  • Eli Lilly and Company long term debt for 2024 were 29.47B, a 54.28% increase from 2023.
  • Eli Lilly and Company long term debt for 2023 were 19.10B, a 28.95% increase from 2022.
  • Eli Lilly and Company long term debt for 2022 were 14.82B.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Eli Lilly and Company Annual Long Term Debt (Millions of US $)
2025$40,868
2024$29,474
2023$19,105
2022$14,815
2021$16,741
2020$16,349
2019$13,639
2018$9,196
2017$9,941
2016$9,006
2015$7,979
2014$5,333
2013$5,213
2012$5,531
2011$6,982
Eli Lilly and Company Quarterly Long Term Debt (Millions of US $)
2025-12-31$40,868
2024-12-31$29,474
2023-12-31$19,105
2022-12-31$14,815
2021-12-31$16,741
2020-12-31$16,349
2019-12-31$13,639
2018-12-31$9,196
2017-12-31$9,941
2016-12-31$9,006
2015-12-31$7,979
2014-12-31$5,333
2013-12-31$5,213
2012-12-31$5,531
2011-12-31$6,982
2010-12-31$6,789
2009-12-31$6,655
2008-12-31$4,616

Eli Lilly and Company Long Term Debt — FAQ

Eli Lilly and Company (LLY) long term debt over the last 19 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LLY's long term debt history?

The chart and table above show Eli Lilly and Company's long term debt by year and by quarter, including the growth rate.